Unplanned hospital readmissions mean a significant burden for health systems. Accurately estimating the patient’s readmission risk could help to optimise the discharge decision-making process by smartly ordering patients based on a severity score, thus helping to improve the usage of clinical resources. A great number of heterogeneous factors can influence the readmission risk, which makes it highly difficult to be estimated by a human agent. However, this score could be achieved with the help of AI models, acting as aiding tools for decision support systems. In this paper, we propose a machine learning classification and risk stratification approach to assess the readmission problem and provide a decision support system based on estimated patient risk scores.

This research aims to evaluate the Type 2 Diabetes (T2D) diagnosis and prognosis power from heterogeneous environmental, lifestyle and biochemistry data. Model estimation has previously addressed three main actions as: 1) Missing-value imputation using specific univariant and multivariant imputers accommodated to each particular feature; 2) Quasi-constancy detection in variables; 3) Constructing geographical pollution and rent data from municipality information. Next, different T2D diagnosis and prognosis models are fitted and evaluated, showing increasing performance as more specific features become available while the prediction cost rises as a consequence of requiring more specific data. Finally, four models are obtained: two of them for T2D diagnosis and the other two for T2D prognosis respectively, with performances ranging from 73.3 to 95.41 AUC-ROC. One pair of diagnosis and prognosis models were thought for a global testing that can be done in general locations by only asking general lifestyle-related questions. On the other hand, the other pair, which achieves higher performances, is thought to be applied in a clinical environment where it is easy to obtain more specific biochemistry measures.